A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia

Acute myeloid leukemia (AML) arises from the cells of myeloid lineage and is the most frequent leukemia type in adulthood accounting for about 80% of all cases. The most common treatment strategy for the treatment of AML includes chemotherapy, in rare cases radiotherapy and stem cell and bone marrow...

Descripción completa

Detalles Bibliográficos
Autores principales: Aru, Başak, Pehlivanoğlu, Cemil, Dal, Zeynep, Dereli-Çalışkan, Nida Nur, Gürlü, Ege, Yanıkkaya-Demirel, Gülderen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895857/
https://www.ncbi.nlm.nih.gov/pubmed/36742324
http://dx.doi.org/10.3389/fimmu.2023.1108200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895857/
https://www.ncbi.nlm.nih.gov/pubmed/36742324
http://dx.doi.org/10.3389/fimmu.2023.1108200

Ejemplares similares